ATPC
Agape ATP Corporation
There isn't enough reported data to score ATPC yet.
CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
ATPC Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
ATPC's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
ATPC PE Valuation
ATPC has no meaningful PE right now: it lost money over the past year.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
ATPC Forward outlook
There aren't enough analyst estimates for ATPC to show an outlook.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
ATPC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.06 | +$19.86 |
| Q1 2026 | -$1.71 | +$28.71 |
| Q4 2025 | -$4.88 | +$32.04 |
| Q3 2025 | -$14.92 | +$31.58 |
| Q2 2025 | -$20.92 | +$19.08 |
| Q1 2025 | -$30.42 | -$0.42 |
| Q4 2024 | -$36.92 | -$6.92 |
| Q3 2024 | -$46.50 | -$28.27 |
ATPC is still losing money, but far less than before: $1.06 per share over the past year, against $46.50 at its worst in late 2024.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over ATPC on earnings quality, reporting a profit while its opponent remains loss making.
ATPC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $109.1K | -77% |
| Q1 2026 | $273.7K | -5.3% |
| Q4 2025 | $399.1K | +11% |
| Q3 2025 | $370.6K | +12% |
| Q2 2025 | $465.5K | +49% |
| Q1 2025 | $289K | -9.3% |
| Q4 2024 | $359.8K | -8% |
| Q3 2024 | $331.3K | -6.8% |
ATPC's revenue has slid since its 2020 peak: $109,098 last quarter, down 77% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -505% | -368 points |
| Q1 2026 | -248% | +1.7 points |
| Q4 2025 | -325% | -90 points |
| Q3 2025 | -162% | +3.2 points |
| Q2 2025 | -137% | +8.1 points |
| Q1 2025 | -249% | -22 points |
| Q4 2024 | -236% | +24 points |
| Q3 2024 | -165% | -76 points |
ATPC's operating margin was −505% last quarter, down 368 points from the same quarter a year ago, near the bottom of its range since 2019.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over ATPC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over ATPC on profitability, with a higher operating margin.
ATPC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$110.3K | +$384.1K |
| Q4 2025 | -$208.3K | +$437K |
| Q3 2025 | -$256.7K | +$168.1K |
| Q2 2025 | -$494.5K | -$81.9K |
| Q1 2025 | -$1.5M | -$210.4K |
| Q4 2024 | -$645.3K | +$360.8K |
| Q3 2024 | -$424.9K | -$171.3K |
| Q2 2024 | -$412.5K | +$57.1K |
CELH has the stronger cash trend. Its trailing FCF is up 100% versus its history, compared with ATPC at up 35%.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
ATPC Net Leverage
ATPC's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
ATPC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.0 | Oversold |
| Stochastic | 8.7 | Oversold |
ATPC's weekly RSI is 30 (oversold) and its Stochastic is 9 (oversold).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
ATPC PE vs Consumer Defensive Sector
ATPC has no meaningful PE right now: it lost money over the past year.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
ATPC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.69 | 20% below |
| 20 week MA | $2.19 | 38% below |
| 50 week MA | $4.08 | 67% below |
| 100 week MA | $36.2 | 96% below |
CELH has stronger trend alignment. ATPC is above 0 of 4 weekly averages versus CELH above 2 of 5.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
ATPC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $8,100.0 | $639.0 | -92% |
| 2024 | $639.0 | $57.5 | -91% |
| 2025 | $57.5 | $6.04 | -89% |
| 2026 YTD | $6.04 | $1.36 | -77% |
ATPC has finished every year since 2023 lower, and it's down 77% so far in 2026.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over ATPC on returns for 2026, with the stronger performance.